Consumer Products
Therapy
Cancer Prevention

Marker Therapeutics

$5.95
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.12 (-1.96%) Today
-$0.04 (-0.67%) After Hours

Why Robinhood?

You can buy or sell MRKR and other stocks, options, ETFs, and crypto commission-free!

About

Marker Therapeutics, Inc. Common Stock, also called Marker Therapeutics, is an immuno-oncology company, which engages in the development of technologies for the treatment of cancer, including metastasis, and infectious diseases. Read More It also involves in developing vaccines for breast, colorectal, ovarian, and non-small cell lung cancer. The company was founded in 1991 and is headquartered in Houston, TX.

Employees
11
Headquarters
Houston, Texas
Founded
1991
Market Cap
277.64M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
309.18K
High Today
$6.08
Low Today
$5.60
Open Price
$6.07
Volume
201.28K
52 Week High
$13.55
52 Week Low
$2.58

Collections

Consumer Products
Therapy
Cancer Prevention
Retail
Health
US
North America

Earnings

Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
Actual
Expected Mar 21, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.